Brand Name Only; Mobile Cryogenic Transfer Operations Platform/MVE Cryo Carts (MVE Part #14448703)
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Centers for Disease Control and Prevention (CDC) is soliciting quotes for four (4) MVE Cryo Carts (MVE part number 14448703), which are Mobile Cryogenic Transfer Operations Platforms. This is a brand name only requirement, set aside 100% for small business concerns. Quotes are due by April 22, 2026.
Scope of Work
The requirement is for four (4) MVE Cryo Carts with temperature recorder and plumbing (MVE part number 14448703). These platforms are essential for maintaining uninterrupted cold-chain integrity and sample preservation, meeting CDC Biorepository technical specifications, ensuring compatibility with existing liquid nitrogen (LN2) infrastructure, and supporting compliance with CAP BAP standards.
Contract & Timeline
- Type: Request for Quotation (RFQ), Firm-Fixed-Price contract
- Set-Aside: Total Small Business Set-Aside (100%)
- NAICS: 334516 (Laboratory Equipment And Supplies)
- Response Due: April 22, 2026, 6:00 PM ET
- Published: April 16, 2026
Evaluation
The CDC will award a firm-fixed-price contract to the offeror providing a technically acceptable quote with the lowest evaluated price. Offerors must provide dollar amounts for line items or a separate spreadsheet with item details, quantities, units, and options.
Additional Notes
This acquisition is for a specific brand-name product, MVE Cryo Carts, due to stringent technical, compatibility, and accreditation standards required by the CDC Biorepository. Market research confirmed MVE as the sole manufacturer meeting all necessary requirements. The solicitation incorporates provisions and clauses by reference, accessible at www.acquisition.gov.